Lovastatin and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

We study 31,086 people who have side effects when taking Lovastatin. Common peroneal nerve dysfunction is found, especially among people who are female, 60+ old, also take Aspirin and have Stress and anxiety.

The phase IV clinical study analyzes which people take Lovastatin and have Common peroneal nerve dysfunction. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

31,086 people reported to have side effects when taking Lovastatin.
Among them, 19 people (0.06%) have Common peroneal nerve dysfunction.

What is Lovastatin?

Lovastatin has active ingredients of lovastatin. It is used in high blood cholesterol. Currently, eHealthMe is studying from 32,252 Lovastatin users.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 1,594 drugs and 1,073 conditions by eHealthMe. Currently, we are studying 7,487 people who have Common peroneal nerve dysfunction.

Number of Lovastatin and Common peroneal nerve dysfunction reports submitted per year:

Could Lovastatin cause Common peroneal nerve dysfunction?

Gender of people who have Common peroneal nerve dysfunction when taking Lovastatin *:

female: 94.44 %
male: 5.56 %

Age of people who have Common peroneal nerve dysfunction when taking Lovastatin *:

Common drugs people take besides Lovastatin *:

Common side effects people have besides Common peroneal nerve dysfunction *:

Fatigue (feeling of tiredness): 14 people, 73.68%
Breathing Difficulty: 13 people, 68.42%
Fall: 13 people, 68.42%
Weakness: 12 people, 63.16%
Muscle Spasms (muscle contraction): 11 people, 57.89%
Neoplasm Malignant (cancer tumour): 10 people, 52.63%
Head Injury: 10 people, 52.63%
Weight Decreased: 9 people, 47.37%
Tooth Loss: 8 people, 42.11%
Pain: 8 people, 42.11%

Common conditions people have *:

Stress And Anxiety: 8 people, 42.11%
Metastases To Bone (cancer spreads to bone): 7 people, 36.84%
Depression: 5 people, 26.32%
Pain: 5 people, 26.32%
Muscle Spasms (muscle contraction): 4 people, 21.05%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 15.79%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.79%
Cardiac Failure Congestive: 3 people, 15.79%
Asthma: 2 people, 10.53%
Cardiac Disorder: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Lovastatin and have Common peroneal nerve dysfunction?

Check whether Common peroneal nerve dysfunction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Lovastatin side effects by duration, gender and age:

Lovastatin side effects (32,252 reports)

Common peroneal nerve dysfunction treatments and more:

Common peroneal nerve dysfunction (7,487 reports)

Common drugs associated with Common peroneal nerve dysfunction:

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin (the active ingredients of Lovastatin) and Lovastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.